Skip to content

Faecal Immunochemical Test and Urine Volatile Compounds in Adenoma Detection

The Performance of Faecal Immunochemical Test and Urinary Volatile Compounds in the Detection of Colorectal Adenomas and Their Role in Polyp Surveillance

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04146662
Acronym
FASt
Enrollment
360
Registered
2019-10-31
Start date
2019-10-16
Completion date
2022-03-31
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Bowel cancer can arise from polyps, which can become cancerous. Polyps are little outgrowths within the lining of the bowel (similar to skin warts). Depending on their size and their potential to become cancerous, they can cause bleeding. However, it is not known which polyps harbour cancerous potential. Therefore, at present all patients undergo a colonoscopy (camera examination of the large bowel) in order to identify and remove any polyps. However, not all patients who undergo a colonoscopy will have polyps. Moreover, colonoscopies are invasive and disruptive to patients, as they require bowel preparation. The aim of this study is to evaluate non-invasive stool and urine tests to identify patients who are at risk of polyps and if the polyps have the potential to become cancerous. This in turn, will significantly reduce the number of 'unnecessary' polyp surveillance colonoscopies with resultant benefits to both patients and the National Health Service (NHS).

Interventions

Faecal immunochemical test (FIT) and urine volatile organic compounds (VOC) analysis.

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are on a polyp surveillance programme and will be undergoing colonoscopy examination for polyp surveillance OR Patients who will be undergoing elective polypectomy through specialised polyp multi-disciplinary meetings.

Exclusion criteria

* Participants who are unable to attend colonoscopy * Under 18 years old * Unable to provide informed consent for themselves to take part in this study

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of Faecal immunochemical test and urine volatile markers to detect colorectal adenomasThrough study completion, an average of 2 yearsTo determine the sensitivity of Faecal immunochemical test and urine volatile markers to detect colorectal adenomas - individually and in combination, in comparison to colonoscopy results (histology findings).

Secondary

MeasureTime frameDescription
Sensitivity of Faecal immunochemical test and urine volatile markers for all adenomas and high-grade adenomasThrough study completion, an average of 2 yearsTo determine the specificity and receiver operator curve for Faecal immunochemical test and urine volatile markers for all adenomas and high-grade adenomas.
Positivity threshold for Faecal immunochemical test and urine volatile markersThrough study completion, an average of 2 yearsTo determine the positivity threshold for FIT and urine VOC for detection of adenomas, comparing all adenomas vs high grade adenomas.
Volatile chemicals in urine in those with adenomasThrough study completion, an average of 2 yearsTo identify the specific volatile chemicals that are consistently present in those with adenomas.
To determine the sensitivity of blood markers for the detection of colorectal adenomasThrough study completion, an average of 2 yearsTo determine the sensitivity of blood markers e.g. Septin 9 for the detection of colorectal adenomas

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026